Lupin Expands Canada Specialty Portfolio with Spektus Deal for DeslaFlex
Global pharmaceutical company Lupin Limited has entered into a licensing and supply agreement with Spektus Pharma to commercialize DeslaFlex in Canada, marking a strategic move to strengthen its central nervous system (CNS) portfolio in the region.











